Clinical Trials List
2010-02-01 - 2011-01-31
Phase II
Terminated13
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 郭律成 Division of Thoracic Medicine
- Shih-Chi Ku Division of Thoracic Medicine
- Ping-Hung Kuo Division of Thoracic Medicine
- 鄭之勛 Division of Thoracic Medicine
- 蔡子修 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 梁信杰 Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
- 邱國樑 Division of Thoracic Medicine
- Yu-Chao Lin Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 傅瑞英 Division of Thoracic Medicine
- Meng-Jer Hsieh Division of Thoracic Medicine
- 周晏立 Division of Thoracic Medicine
- 倪永倫 Division of Thoracic Medicine
- Ning-Hung Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蘇茂昌 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- 劉世豐 Division of Thoracic Medicine
- 吳沼漧 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林明澤 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 覃俊士 Division of Thoracic Medicine
- 沈光漢 Division of Thoracic Medicine
- Ming -Cheng Chan Division of Thoracic Medicine
- 王振宇 Division of Thoracic Medicine
- Chieh-Liang Wu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
390 participants
